Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K
Ligand Binding Sites02:40

Ligand Binding Sites

9.1K
9.1K
Conserved Binding Sites01:49

Conserved Binding Sites

5.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

6.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
6.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.3K
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human BBB-brain organoid on a millifluidic plate for modeling brain parenchymal pathology-induced barrier dysfunction.

Journal of advanced research·2026
Same author

Prevalence and a LASSO-derived prediction model for screening-positive mild cognitive impairment among older adults in Wuhan.

Scientific reports·2026
Same author

Epidemiology of Rheumatoid Arthritis in the Asia-Pacific Region: A Systematic Analysis of the Global Burden of Disease Study 1990-2023 and Forecasts to 2025.

International journal of rheumatic diseases·2026
Same author

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

mAbs·2026
Same author

Network for Real-time Laryngeal Lesions Video Object Detection.

Journal of imaging informatics in medicine·2026
Same author

Nanocollision promotes locomotion of dendritic cells for tumor therapy.

Science advances·2026

Related Experiment Video

Updated: Apr 9, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

130

Knowledge-Based Strategy to Improve Ligand Pose Prediction Accuracy for Lead Optimization.

Cen Gao, Nels Thorsteinson1, Ian Watson

  • 1§Chemical Computing Group Inc., 1010 Sherbrooke St. W, Suite 910, Montreal, Quebec H3A 2R7, Canada.

Journal of Chemical Information and Modeling
|June 20, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces an automated method for predicting small molecule binding poses, significantly improving accuracy in structure-based drug design. The protocol leverages existing X-ray data for enhanced drug discovery and lead optimization.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

4.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K

Related Experiment Videos

Last Updated: Apr 9, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

130
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

4.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Medicinal chemistry

Background:

  • Accurate small molecule-protein binding prediction is crucial for structure-based drug design (SBDD).
  • Current methods often apply binding pose prediction after related crystal structures are available.
  • Existing techniques require improvement for efficient lead optimization.

Purpose of the Study:

  • To develop and validate an automated protocol for accurate small molecule binding pose prediction.
  • To enhance the efficiency of structure-based drug design by utilizing existing X-ray ligand information.
  • To demonstrate the practical utility of the protocol in drug discovery projects.

Main Methods:

  • Developed an automated pose prediction protocol using spatial restraints during docking.
  • Employed maximum common substructure (MCS) overlap between candidate molecules and known X-ray structures.
  • Validated the protocol using a large dataset of 8784 docking runs.

Main Results:

  • Achieved a pose prediction accuracy of 80-82%, nearly double that of an unbiased docking method (43%).
  • Demonstrated high applicability of the algorithm in medicinal chemistry efforts, exceeding 70% success rate.
  • Showcased the protocol's utility through chronological application in internal drug discovery projects.

Conclusions:

  • The developed protocol offers a significant advancement in automated binding pose prediction for SBDD.
  • Its high accuracy and applicability make it a preferred approach for pose prediction in lead optimization.
  • This method enhances the efficiency and success rate of structure-based drug design programs.